This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Sanofi. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Sabine Scheidler: Innovator in RNA Therapeutics
Introduction
Sabine Scheidler is a prominent inventor based in Frankfurt, Germany. She has made significant contributions to the field of RNA therapeutics, particularly in the area of gene expression regulation. Her work focuses on innovative methods to inhibit specific gene expressions that are associated with various medical conditions.
Latest Patents
Sabine holds a patent for "RNA compositions and methods for inhibiting ANGPTL8." This patent involves double-stranded RNAs (dsRNAs) that target the ANGPTL8 gene. The methods described in her patent aim to inhibit ANGPTL8 gene expression and provide potential treatments for conditions linked to this gene.
Career Highlights
Sabine Scheidler is currently employed at Sanofi, a global biopharmaceutical company. Her role at Sanofi allows her to work on cutting-edge research and development in the field of RNA-based therapies. With her expertise, she contributes to advancing medical science and improving patient outcomes.
Collaborations
Some of her notable coworkers include Kerstin Jahn-Hofmann and Christiane Metz-Weidmann. Together, they collaborate on various projects that aim to enhance the understanding and application of RNA technologies in medicine.
Conclusion
Sabine Scheidler's innovative work in RNA therapeutics exemplifies the impact of scientific research on healthcare. Her contributions, particularly in inhibiting ANGPTL8 gene expression, hold promise for future medical advancements.